Executive Summary
Summary Nordic Bioscience AS (Nordic Bioscience), formerly Danish Biotech Co is a preclinical and clinical drug development company that offers serological biochemical solutions. The company offers diagnostic products, laboratory kits and biochemical assays. It provides degradation biomarkers, formation biomarkers, intracellular biomarkers and protease biomarkers. Nordic Bioscience's services include research and development, clinical development, protocol design, risk based monitoring and data management, assay development, ECM profiling and sample measurement, and disease specific biomarker solutions. The company serves in the therapeutic areas of cardiovascular system, oncology, rheumatology, central nervous system, respiratory system, hepatic system, hematology, muscle, renal system and endocrinology. It caters to biotech and pharmaceutical companies to identify projects that are suitable for clinical development by utilizing biomarker technology. Nordic Bioscience is headquartered in Copenhagen, Denmark. Nordic Bioscience AS-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions. GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research. Scope - Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. - Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. - Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. - Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. - Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector. - Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios. - Business Description-A brief description of the company's operations. - Key Employees-A list of the key executives of the company. - Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company. - Key Competitors-A list of the key competitors of the company. - Key Recent Developments-A brief on recent news about the company. Reasons to buy Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements - The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period. Understand the company's business segments' expansion / divestiture strategy - The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy. Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios. Equip yourself with detailed information about the company's operations to identify potential customers and suppliers. - The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors. Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events. Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs. Note*: Some sections may be missing if data is unavailable for the company.
Read More
Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
ankur [@] kenresearch.com
+91-9015378249
Table of Contents Table of Contents 3 List of Tables 4 List of Figures 4 Nordic Bioscience AS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5 Nordic Bioscience AS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6 Nordic Bioscience AS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7 Nordic Bioscience AS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8 Nordic Bioscience AS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9 Nordic Bioscience AS, Pharmaceuticals & Healthcare, Deal Details 10 Partnerships 10 Bristol-Myers Squibb Enters into Agreement with Nordic Bioscience 10 Grunenthal, Nordic Bioscience and Argenta Discovery Enter into Research Agreement 11 Symic Biomedical Enters into Co-Development Agreement with Nordic Bioscience 12 Merck Enters Into Co-Development Agreement With Nordic Bioscience For Sprifermin 13 Licensing Agreements 14 Enteris BioPharma Enters Into Licensing Agreement With KeyBioScience 14 Unigene Labs And Nordic Bioscience Enter Into Licensing Agreement For Metabolic Peptide Analogs 15 Nordic Bioscience AS-Key Competitors 16 Nordic Bioscience AS-Key Employees 17 Nordic Bioscience AS-Locations And Subsidiaries 18 Head Office 18 Other Locations & Subsidiaries 18 Appendix 19 Methodology 19 About GlobalData 19 Contact Us 19 Disclaimer 19
List of Tables Nordic Bioscience AS, Pharmaceuticals & Healthcare, Key Facts 2 Nordic Bioscience AS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5 Nordic Bioscience AS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6 Nordic Bioscience AS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7 Nordic Bioscience AS, Deals By Therapy Area, 2012 to YTD 2018 8 Nordic Bioscience AS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9 Bristol-Myers Squibb Enters into Agreement with Nordic Bioscience 10 Grunenthal, Nordic Bioscience and Argenta Discovery Enter into Research Agreement 11 Symic Biomedical Enters into Co-Development Agreement with Nordic Bioscience 12 Merck Enters Into Co-Development Agreement With Nordic Bioscience For Sprifermin 13 Enteris BioPharma Enters Into Licensing Agreement With KeyBioScience 14 Unigene Labs And Nordic Bioscience Enter Into Licensing Agreement For Metabolic Peptide Analogs 15 Nordic Bioscience AS, Key Competitors 16 Nordic Bioscience AS, Key Employees 17 Nordic Bioscience AS, Subsidiaries 18
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
Nordic Bioscience AS, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
|
Agriculture and Animal Care
Automotive, Transportation and Warehousing
Banking Financial Services and Insurance
Consumer Products and Retail
Defense and Security
Education and Recruitment
Energy and Utilities
Food, Beverage and Tobacco
Healthcare
Manufacturing and Construction
Media and Entertainment
Metal, Mining and Chemicals
Public Sector and Administration
Technology and Telecom
